These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet hyporesponsiveness to epinephrine in carriers of Bartter's syndrome. O'Regan S; Rivard GE; Cole C; Robitaille PO Prostaglandins Med; 1979 May; 2(5):321-4. PubMed ID: 550149 [TBL] [Abstract][Full Text] [Related]
3. A defect in platelet aggregation in Bartter's syndrome. Stoff JS; Stemerman M; Steer M; Salzman E; Brown RS Am J Med; 1980 Feb; 68(2):171-80. PubMed ID: 6243857 [TBL] [Abstract][Full Text] [Related]
4. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. Di Virgilio F; Calò L; Cantaro S; Favaro S; Piccoli A; Borsatti A Clin Sci (Lond); 1987 Apr; 72(4):483-8. PubMed ID: 3829597 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin suppresses plasma aldosterone concentration in a case of Bartter's syndrome. Shigeta H; Tasaki N; Kitazumi S; Kitagawa Y; Nakano K; Kanatsuna T; Kondo M Endocrinol Jpn; 1987 Apr; 34(2):309-12. PubMed ID: 2887425 [TBL] [Abstract][Full Text] [Related]
6. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome. Horký K; Schreiber V; Dvoráková J Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182 [TBL] [Abstract][Full Text] [Related]
15. Correction of hypokalemia corrects the abnormalities in erythrocyte sodium transport in Bartter's syndrome. Korff JM; Siebens AW; Gill JR J Clin Invest; 1984 Nov; 74(5):1724-9. PubMed ID: 6501567 [TBL] [Abstract][Full Text] [Related]
16. Lymphocytic sodium and potassium pump function in Bartter's syndrome. Jest P; Pedersen KE; Klitgaard NA; Thomsen N; Kjaer E; Simonsen E; Jacobsen JG Acta Endocrinol (Copenh); 1989 Jul; 121(1):61-6. PubMed ID: 2741641 [TBL] [Abstract][Full Text] [Related]
17. Indomethacin and atrial natriuretic peptide in Bartter's syndrome. Gordon RD; Tunny TJ; Klemm SA N Engl J Med; 1986 Aug; 315(7):459. PubMed ID: 2942775 [No Abstract] [Full Text] [Related]
18. Is the platelet defect in Bartter's syndrome associated with a plasma prostaglandin? MacIntyre DE; Smith M; Levine L; Stoff JS; Stemerman M; Steer ML; Salzman EW; Brown RS Adv Prostaglandin Thromboxane Res; 1980; 7():1199-202. PubMed ID: 7369031 [No Abstract] [Full Text] [Related]
19. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Watanabe S; Fukumoto S; Chang H; Takeuchi Y; Hasegawa Y; Okazaki R; Chikatsu N; Fujita T Lancet; 2002 Aug; 360(9334):692-4. PubMed ID: 12241879 [TBL] [Abstract][Full Text] [Related]
20. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man. Gordon RD; Tunny TJ; Klemm SA; Hamlet SM J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]